Inflammatory breast cancer: the evolution of multimodality treatment strategies.
Inflammatory breast cancer is an aggressive subtype of invasive breast cancer. Early attempts to control the disease with local treatment modalities alone had a minimal impact on survival. More recently, multimodality treatment approaches that integrate systemic chemotherapy, surgery, and radiotherapy have resulted in improved local disease control and prolonged survival. Better systemic therapies need to be developed since metastatic disease develops in the majority of patients.
Gradishar
W J
WJ
Department of Medicine, Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, Illinois, USA.
D000230:Adenocarcinoma / Q000145:classification / Q000175:diagnosis / Q000601:surgery*; D001943:Breast Neoplasms / Q000145:classification / Q000175:diagnosis / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008327:Mammography; D008408:Mastectomy; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis